Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study.
Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study. BMC Gastroenterol. 2009 Mar 20; 9:22.